Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.

Writing Committee for the REMAP-CAP Investigators, Paul Dark

Research output: Contribution to journal › Article › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{c379429868f04ef49f9800886907cb62,

title = "Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.",

author = "Investigators, {Writing Committee for the REMAP-CAP} and Paul Dark",

year = "2022",

month = dec,

day = "1",

doi = "10.1001/jama.2022.23257",

language = "Undefined",

journal = "JAMA",

issn = "0098-7484",

publisher = "American Medical Association",

}

TY - JOUR

T1 - Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.

AU - Investigators, Writing Committee for the REMAP-CAP

AU - Dark, Paul

PY - 2022/12/1

Y1 - 2022/12/1

UR - http://europepmc.org/abstract/med/36525245

U2 - 10.1001/jama.2022.23257

DO - 10.1001/jama.2022.23257

M3 - Article

C2 - 36525245

SN - 0098-7484

JO - JAMA

JF - JAMA

ER -